Article

Quantitative assessment of the evolution of cerebellar signs in spinocerebellar ataxias.

Department of Biostatistics and Medical Informatics and Pitié-Salpêtrière Charles-Foix Clinical Research Unit, AP-HP, Paris, France.
Movement Disorders (impact factor: 4.51). 02/2011; 26(3):534-8. DOI:10.1002/mds.23531 pp.534-8
Source: PubMed

ABSTRACT Responsive ataxia rating scales are essential for determining outcome measures in clinical trials.
We evaluated the responsiveness over time of the composite cerebellar functional severity score, a quantitative score measuring cerebellar ataxia in 133 patients with autosomal dominant cerebellar ataxias (ADCA), which were prospectively evaluated at inclusion and after one-year of follow-up. A more responsive tool was developed, the Cerebellar Functional Severity score writing, incorporating the writing test at dominant hand to the Cerebellar Functional Severity score.
Within the one-year follow-up period, the Cerebellar Functional Severity score and its writing version increased significantly and the Scale for the Assessment and Rating of Ataxia decreased significantly reflecting increased severity of the cerebellar symptoms. The Cerebellar Functional Severity score writing responsiveness was best in genotypes SCA1, 2, and 3 compared with the other genotypes (effect size = 0.196, standardized response mean (SRM) = 0.624 versus effect size = -0.051, SRM = -0.150). The Cerebellar Functional Severity score writing used as an outcome measure would require only 163 SCA1, 2, or 3 patients per group in a two-arm interventional trial for a 50% reduction in progression and 80% of power.
Our study demonstrates that the Cerebellar Functional Severity score and Cerebellar Functional Severity score writing are responsive quantitative scores for evaluating sensitivity to change in ADCA patients and can be used as outcome measures in clinical trials, especially when targeting genotypes SCA1, 2 and 3.

0 0
 · 
0 Bookmarks
 · 
73 Views

Keywords

3 patients
 
50% reduction
 
ADCA
 
ADCA patients
 
autosomal dominant cerebellar ataxias
 
Cerebellar Functional Severity score
 
clinical trials
 
composite cerebellar functional severity score
 
effect size
 
genotypes SCA1
 
one-year
 
one-year follow-up period
 
progression
 
Responsive ataxia rating scales
 
responsive tool
 
severity
 
standardized response
 
two-arm interventional trial
 
writing test
 
writing version